Neuland Laboratories enters into JDA with Phoenix Embassy Techno Zone

22 May 2017 Evaluate

Neuland Laboratories has entered into a Joint Development Agreement (JDA) with Phoenix Embassy Techno Zone (Developer) for development of the land owned by the company at Nanakramguda. The company has requested the developer to arrange for the sale of 0.12 million square feet out of the company’s share. To comply with its obligations under the JDA, the developer nominated Star Bio Products LLP and Premier IT Developers (Developer’s Nominees) to acquire the 0.12 million square feet out of the company’s share on terms that shall be agreed to between the Developer’s Nominees and the company.

Besides, the company has entered into a Supplementary Development Agreement (SDA) with the Developer and others to define, identify, demarcate, allot and allocate Leasable / Saleable Area between the parties in the project and record the commitment of Developer’s Nominees to acquire 0.12 million square feet out of the company’s share.

Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.


Neuland Laboratories Share Price

14935.20 -27.65 (-0.18%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×